ArticleFrontiers in immunology2020

Pharmaco-Optogenetic Targeting of TRPC Activity Allows for Precise Control Over Mast Cell NFAT Signaling.

Bernadett Bacsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.